HCA
Harbor Capital Advisors Portfolio holdings
AUM
$2.38B
This Quarter Return
-0.28%
1 Year Return
+20%
3 Year Return
+97.89%
5 Year Return
–
10 Year Return
–
AUM
$109M
AUM Growth
+$109M
(-17%)
Cap. Flow
-$12.5M
Cap. Flow
% of AUM
-11.48%
Top 10 Holdings %
Top 10 Hldgs %
32.93%
Holding
164
New
4
Increased
20
Reduced
133
Closed
7
Top Buys
| 1 |
Tesla
TSLA
|
$2.47M |
| 2 |
Alphabet (Google) Class C
GOOG
|
$2M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
$1.95M |
| 4 |
Danaher
DHR
|
$1.09M |
| 5 |
Datadog
DDOG
|
$889K |
Top Sells
| 1 |
Atlassian
TEAM
|
$3.13M |
| 2 |
AVLR
Avalara, Inc.
AVLR
|
$1.89M |
| 3 |
ZEN
ZENDESK INC
ZEN
|
$1.7M |
| 4 |
Twilio
TWLO
|
$1.19M |
| 5 |
Microsoft
MSFT
|
$823K |
Sector Composition
| 1 | Technology | 46.38% |
| 2 | Healthcare | 23.56% |
| 3 | Consumer Discretionary | 16.98% |
| 4 | Communication Services | 8.67% |
| 5 | Financials | 1.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
NVIDIA
NVDA
$4.24T
| $714K | 0.66% |
5,881
-18
| -0.3% | -$2.19K |
|
52
Avidity Biosciences
RNA
$5.99B
| $691K | 0.63% |
42,294
-4,648
| -10% | -$75.9K |
|
53
Eli Lilly
LLY
$657B
| $664K | 0.61% |
+2,053
| New | +$664K |
|
54
Allogene Therapeutics
ALLO
$251M
| $662K | 0.61% |
61,294
-28,698
| -32% | -$310K |
|
|
AMED
55
DELISTED
Amedisys
AMED
| $628K | 0.58% |
6,486
-719
| -10% | -$69.6K |
|
56
Idexx Laboratories
IDXX
$51.8B
| $616K | 0.57% |
1,892
-210
| -10% | -$68.4K |
|
57
Arvinas
ARVN
$568M
| $587K | 0.54% |
13,204
-1,441
| -10% | -$64.1K |
|
58
Cooper Companies
COO
$13.4B
| $583K | 0.54% |
2,211
-242
| -10% | -$63.8K |
|
59
Arrowhead Research
ARWR
$3.05B
| $578K | 0.53% |
17,489
-1,910
| -10% | -$63.1K |
|
60
Bio-Rad Laboratories Class A
BIO
$8.06B
| $572K | 0.53% |
1,372
-153
| -10% | -$63.8K |
|
|
AKUS
61
DELISTED
Akouos, Inc. Common Stock
AKUS
| $570K | 0.52% |
84,358
+3,604
| +4% | +$24.4K |
|
62
Mettler-Toledo International
MTD
$26.8B
| $560K | 0.51% |
517
-58
| -10% | -$62.8K |
|
63
Thermo Fisher Scientific
TMO
$186B
| $555K | 0.51% |
1,095
-374
| -25% | -$190K |
|
64
NextEra Energy, Inc.
NEE
$148B
| $519K | 0.48% |
6,624
-732
| -10% | -$57.4K |
|
65
Replimune Group
REPL
$422M
| $477K | 0.44% |
27,644
-3,051
| -10% | -$52.6K |
|
66
uniQure
QURE
$896M
| $423K | 0.39% |
22,535
-1,195
| -5% | -$22.4K |
|
|
CTLT
67
DELISTED
CATALENT, INC.
CTLT
| $411K | 0.38% |
5,678
-5,164
| -48% | -$374K |
|
68
Zoom
ZM
$24.4B
| $403K | 0.37% |
5,479
-870
| -14% | -$64K |
|
69
Iovance Biotherapeutics
IOVA
$807M
| $358K | 0.33% |
37,401
-2,033
| -5% | -$19.5K |
|
|
AUTL
70
Autolus Therapeutics
AUTL
$399M
| $318K | 0.29% |
148,454
-16,452
| -10% | -$35.2K |
|
71
Synlogic
SYBX
$17M
| $302K | 0.28% |
318,309
-35,456
| -10% | -$33.6K |
|
|
BPMC
72
DELISTED
Blueprint Medicines
BPMC
| $301K | 0.28% |
4,575
-7,760
| -63% | -$511K |
|
|
NVTA
73
DELISTED
Invitae Corporation
NVTA
| $291K | 0.27% |
118,449
+14,531
| +14% | +$35.7K |
|
74
Alkermes
ALKS
$4.78B
| $284K | 0.26% |
+12,718
| New | +$284K |
|
75
Peloton Interactive
PTON
$3.1B
| $275K | 0.25% |
39,704
-8,181
| -17% | -$56.7K |
|